Form 4: Clorox Director Reports Stock Unit Transactions
Insider Transaction Report
Clorox Director Pierre R. Breber reported transactions involving deferred stock units acquired through dividend reinvestment and in lieu of director's fees.
Summary
- Pierre R. Breber, a Director at The Clorox Company, reported transactions related to deferred stock units (DSUs).
- On May 8, 2026, DSUs were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
- On June 30, 2026, DSUs were received in lieu of quarterly director's fees.
- These DSUs are set to be settled 100% in Clorox stock upon the reporting person's retirement or termination of service as a Director.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine compensation transactions for a director rather than significant strategic or financial performance updates.
Positives
- Director Breber's participation in the deferred compensation plan indicates continued engagement and alignment with shareholder interests.
- Dividend reinvestment into DSUs suggests a belief in the company's ability to generate returns and grow shareholder value.
Negatives
- The filing does not contain any negative financial or operational information.
Risks
- The value of the deferred stock units is subject to the future stock price performance of The Clorox Company.
- Potential for changes in the company's dividend policy could impact the rate of DSU accumulation through reinvestment.
Future Outlook
The deferred stock units will be settled in Clorox stock upon the reporting person's retirement or termination of service as a Director, indicating a long-term commitment and alignment with the company's future performance.
Industry Context
StockSavvy.ai notes that the use of deferred stock units and dividend reinvestment plans is a common practice among S&P 500 companies, including those in the consumer staples sector, to attract and retain experienced directors and align their interests with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Deferred Compensation Plan | Acquisition of deferred stock units through dividend reinvestment and in lieu of director's fees under the Independent Directors' Deferred Compensation Plan. | Ongoing | Reinforces director compensation structure and aligns director interests with long-term company performance. |
Related Party Transactions
- Receipt of deferred stock units by Director Pierre R. Breber in lieu of quarterly director's fees.
Stakeholder Impact
- Shareholders: The transactions reflect standard director compensation practices, aligning director incentives with stock performance.
- Employees: Indirect impact through the company's ability to attract and retain qualified board members.
- Management: Standard compensation mechanism for board members.
Next Steps
- Settlement of deferred stock units in Clorox stock upon reporting person's retirement or termination of service as a Director.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Date of earliest transaction reported. |
| 05/08/2026 | Transaction date for deferred stock units acquired through dividend reinvestment. |
| 06/30/2026 | Transaction date for deferred stock units received in lieu of quarterly director's fees. |
| 07/02/2026 | Date of signature for the filing. |
Keywords
Clorox, CLX, Form 4, SEC Filing, Director Compensation, Deferred Stock Units, Insider Transactions, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.